CC
VRTX icon

Corton Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Corton Capital’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,278
Closed -$515K – 425
2024
Q4 		$515K Buy
+1,278
New +$592K 0.3% 12
2024
Q3 		– Sell
-613
Closed -$287K – 676
2024
Q2 		$287K Sell
613
-2,109
-77% -$915K 0.15% 211
2024
Q1 		$1.14M Buy
2,722
+733
+37% +$310K 0.42% 23
2023
Q4 		$809K Buy
1,989
+713
+56% +$263K 0.26% 75
2023
Q3 		$444K Sell
1,276
-701
-35% -$245K 0.22% 119
2023
Q2 		$696K Buy
1,977
+143
+8% +$48.2K 0.33% 56
2023
Q1 		$578K Buy
1,834
+1,038
+130% +$311K 0.4% 39
2022
Q4 		$230K Buy
+796
New +$243K 0.19% 184
2022
Q3 		– Sell
-1,299
Closed -$366K – 377
2022
Q2 		$366K Sell
1,299
-1,364
-51% -$365K 0.35% 103
2022
Q1 		$695K Buy
+2,663
New +$632K 0.3% 62

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return